The proposed study is a multicentre randomised controlled trial investigating the effect of Tachosil sealing of the pancreatic remnant after distal pancreatoduodenectomy on the development of pancreatic fistula.Patients will be randomised to either…
ID
Source
Brief title
Condition
- Gastrointestinal therapeutic procedures
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary outcome is the development of pancreatic fistula. A pancreatic
fistula develops when the closure of the pancreatic remnant fails to heal,
causing a leak of pancreas- derived, enzyme-rich fluid from the pancreatic
ductal system.
A pancreatic fistula is defined as drainage of greater than 50 mL amylase-rich
fluid (> 3-fold elevation above upper limit of normal in serum) per day through
the drains
on or after postoperative day 10.
Pancreatic fistulas will be graded according to international fistula
definition as published by Strasberg based on the clinical impact on the
patient*s hospital course.
Grade 1 Deviation from normal postoperative course without pharmacologic,
endoscopic, surgical or radiologic intervention (certain drugs allowed)
Grade 2 Pharmacologic treatment needed. Includes blood transfusions and total
parenteral nutrition
Grade 3 (a/b) Surgical, endoscopic or interventional radiologic treatment needed
a: Not under general anaesthesia b: Under general anaesthesia
Grade 4 (a/b) Life threatening complications and organ dysfunction
a: Single organ b: Multi-organ
Grade 5 Death due to pancreatic fistula
Secondary outcome
Secondary endpoints are mortality, morbidity and costs.
The mortality rate is defined as the total in-hospital death rate.
Postoperative complications, especially delayed gastric emptying, which is
defined as a nasogastric tube for more than 10 days after surgery, inability to
proceed to a regular diet within 10 days or vomiting for more than 3
consecutive days after the fifth post-operative day.
Length of hospital stay
Medical costs
Background summary
Appropriate closure of the pancreatic remnant after distal pancreatectomy is
still debated. A variety of procedures have been recommended to reduce the
frequency of pancreatic fistula. Resections of the pancreas reaching the left
side of the superior mesenteric vein are defined as distal pancreatectomy. They
are performed less often than resections of the pancreatic head (20 to 30% of
all pancreatic resections owing to a lower incidence of pancreatic disease and
later appearance of clinical symptoms in this part of the organ. However,
continuously improving imaging and diagnostic techniques have resulted in an
increase in the frequency of the procedure. Most resections are performed
electively (84 per cent) for the following indications: chronic pancreatitis
(24 per cent), other benign diseases (22 per cent), malignant diseases (18 per
cent), neuroendocrine tumours (14 per cent) and cysts of the pancreas (6 per
cent). The remaining 16 per cent are emergencies after abdominal trauma.In
recent years the mortality rate after pancreatic resection has decreased
considerably to between 0 and 6 per cent in high-volume centres, but morbidity
remains high, ranging from 10 to 47 per cent Pancreatic fistula and leakage are
the most common and clinically relevant complications, and they are thought to
depend on surgical technique and skill. Because fistula is associated with
local and general complications (pancreatic fluid collection, formation of
intra-abdominal abscesses, wound infection, delayed gastric emptying,
respiratory complications, sepsis), it has important implications for the
patient, the surgeon and the healthcare system. In general, it prolongs
hospital stay for specialized treatment, including re-operation and drainage.
The appropriate technique for closure of the pancreatic remnant is still
debated. There is no evidence whether stapled or hand sewn closure should be
preferred. Since stapled closure is not recommended for the triangular
pancreas, the thick pancreas ( > 1.5 cm), the firm or non-compressible pancreas
and in case of a resection plane to the right of the gastroduodenal artery, in
this study we will use a standardized hand sewn closure.
Topical hemostatic agents applied to the resection surface of the remnant liver
after partial liver resection have shown to be effective in preventing
postoperative bleeding. The group of van Gulik showed that application of
topical hemostatic agents, such as fibrinogen/thrombincoated collagen patch
(TachoSil®, Nycomed, UK Ltd.) has a biliostatic effect, which can be considered
an additional benefit of the use of these devices. The adhesive strength of
TachoSil on the resection surface, however, was superior to other agents.
Results of retrospective studies on recostruction techniques after
pancreatico-duodenectomy suggest that outcome with regard to pancreatic fistula
can be improved using TachoSil®.
Study objective
The proposed study is a multicentre randomised controlled trial investigating
the effect of Tachosil sealing of the pancreatic remnant after distal
pancreatoduodenectomy on the development of pancreatic fistula.
Patients will be randomised to either Tachosil sealing of the pancreatic
remnant after standardized hand sewn closure or conventional closure alone.
Primary endpoint will be the development of pancreatic fistula.
Secondary endpoints will be overall mortality and morbidity and a cost
effectiveness analysis.
Study design
Prospective randomized controlled multi-centre trial with blinding for
treatment allocation of patients and medical personnel except for the surgeon.
Patients will be evaluated according to the inclusion criteria at the
outpatient clinic of participating centres. If eligible, informed consent is
obtained. Inclusion will start after approval of Medical Research Ethical
Committee
Intervention
Conventional closure of the pancreatic remnant
After complete mobilisation of the pancreatic body or tail (up to the region of
the superior mesenteric vein, or at least 2-3 cm central of the planned
resection margin), the resection is performed with a surgical scalpel or
diathermia. After haemostasis the pancreatic duct is closed separately using
PDS 4x0 or 5x0. The pancreatic remnant is closed using continuous mattress
sutures with PDS 3x0 or 4x0.
Closure of the pancreatic remnant by Tachosil seal
In the Tachosil arm, pancreatic resection and transsection of the pancreatic
body will be executed with a surgical scalpel. The main pancreatic duct is
identified and closed using single stitches of 4-0 or 5-0 PDS. The parenchyma
is then closed with single stitches 3x0 or 4x0 PDS. The suture line is
reinforced by placement of a fibrin/ thrombin-coated collagen patch (TachoSil)
onto the transsected end .All participating centre receive a DVD where this
procedure is demonstrated
Study burden and risks
n.a.
Dr Molewaterplein 40
3015GD Rotterdam
NL
Dr Molewaterplein 40
3015GD Rotterdam
NL
Listed location countries
Age
Inclusion criteria
Patients undergoing a distal pancreatectomy
Exclusion criteria
Current immunosuppressive or chemotherapy
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL29396.078.09 |